Sg3 Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Sg3 Management, LLC

$0
Q3 2023

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $9.29 Million - $10.5 Million	-161,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.78 Million - $2.23 Million	30,700 Added 23.56%	161,000 $9.57 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $2.26 Million - $2.57 Million	34,900 Added 36.58%	130,300 $9.46 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $3.93 Million - $4.24 Million	58,000 Added 155.08%	95,400 $6.66 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.9 Million - $2.08 Million	-30,000 Reduced 44.51%	37,400 $2.58 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $2.84 Million - $3.25 Million	47,400 Added 237.0%	67,400 $4.36 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $566,500 - $645,500	10,000 Added 100.0%	20,000 $1.17 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $2.48 Million - $3.12 Million	-40,000 Reduced 80.0%	10,000 $632,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $14,468 - $16,800	200 Added 0.4%	50,000 $3.85 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $3.12 Million - $3.99 Million	49,800 New	49,800 $3.72 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $1.88 Million - $2.07 Million	-30,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $1.86 Million - $2.08 Million	30,000 New	30,000 $2.03 Million
Q3 2017 Jan 25, 2018	SELL	$72.11 - $85.47 $1.07 Million - $1.26 Million	-14,800 Closed	0 $0
Q2 2017 Feb 26, 2018	BUY	N/A	14,652 Added 9900.0%	14,800 $1.05 Million
Q2 2017 Jan 25, 2018	BUY	N/A	148 New	148 $9,000
Q1 2017 Jan 25, 2018	SELL	N/A	-19,500 Closed	0 $0
Q4 2016 Feb 23, 2018	BUY	N/A	19,305 Added 9900.0%	19,500 $1.4 Million
Q4 2016 Jan 24, 2018	BUY	N/A	195	195 $38,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Account